MedPath

Reducing Sugar-sweetened Beverage Consumption Among Young Adults

Not Applicable
Completed
Conditions
Health Knowledge, Attitudes, Practice
Intention
Registration Number
NCT03672578
Lead Sponsor
University of California, Davis
Brief Summary

This study aims to test sugar-sweetened beverage (SSB) health labeling elements in an online experiment to determine which elements are the most salient among young adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2971
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
SSB IntentionUp to 20 minutes

Intention to consume SSBs measured by hypothetical selection of a beverage from images of beverage options.

Secondary Outcome Measures
NameTimeMethod
SSB Intention (2)Up to 20 minutes

Measured by survey items assessing intention to consume SSBs on a scale from 1 (not at all likely) to 7 (extremely likely).

SSB attitudesUp to 20 minutes

Measured by survey items assessing perceived healthfulness of SSBs on a scale from 1 (extremely unhealthy) to 7 (extremely healthy).

SSB knowledgeUp to 20 minutes

Measured by survey items assessing knowledge of number of calories (estimate provided by participant) and sugar (estimated by participant, in teaspoons) contained in SSBs.

SSB normsUp to 20 minutes

Measured by survey item assessing how often participants perceive their peers to consume SSBs (1 = multiple times a day, 2 = daily, 3 = weekly, 4 = less than once a week, and 5 = never) and item on perception that people who are important to the participant would want them to limit SSB intake, on a scale from 1 (not at all) to 5 (completely) .

Trial Locations

Locations (1)

University of California, Davis

🇺🇸

Davis, California, United States

University of California, Davis
🇺🇸Davis, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.